384 related articles for article (PubMed ID: 12667452)
1. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.
Reid G; Hübner MR; Métivier R; Brand H; Denger S; Manu D; Beaudouin J; Ellenberg J; Gannon F
Mol Cell; 2003 Mar; 11(3):695-707. PubMed ID: 12667452
[TBL] [Abstract][Full Text] [Related]
2. Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
Masuyama H; Hiramatsu Y
J Biol Chem; 2004 Mar; 279(13):12020-6. PubMed ID: 14702340
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.
Kinyamu HK; Archer TK
Mol Cell Biol; 2003 Aug; 23(16):5867-81. PubMed ID: 12897156
[TBL] [Abstract][Full Text] [Related]
4. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
Fan M; Bigsby RM; Nephew KP
Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
[TBL] [Abstract][Full Text] [Related]
5. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens.
Hall JM; Korach KS
J Biol Chem; 2002 Nov; 277(46):44455-61. PubMed ID: 12200415
[TBL] [Abstract][Full Text] [Related]
7. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha.
Preisler-Mashek MT; Solodin N; Stark BL; Tyriver MK; Alarid ET
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E891-8. PubMed ID: 11882509
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
Tsai HW; Katzenellenbogen JA; Katzenellenbogen BS; Shupnik MA
Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
[TBL] [Abstract][Full Text] [Related]
9. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.
Stoner M; Saville B; Wormke M; Dean D; Burghardt R; Safe S
Mol Endocrinol; 2002 Oct; 16(10):2231-42. PubMed ID: 12351689
[TBL] [Abstract][Full Text] [Related]
11. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol.
Barchiesi F; Jackson EK; Imthurn B; Fingerle J; Gillespie DG; Dubey RK
J Clin Endocrinol Metab; 2004 May; 89(5):2373-81. PubMed ID: 15126566
[TBL] [Abstract][Full Text] [Related]
13. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
[TBL] [Abstract][Full Text] [Related]
14. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
Wallace AD; Cidlowski JA
J Biol Chem; 2001 Nov; 276(46):42714-21. PubMed ID: 11555652
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
Morelli C; Garofalo C; Bartucci M; Surmacz E
Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
[TBL] [Abstract][Full Text] [Related]
16. The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation.
Moraitis AN; Giguère V
J Biol Chem; 2003 Dec; 278(52):52511-8. PubMed ID: 14570920
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.
Aiyar SE; Sun JL; Blair AL; Moskaluk CA; Lu YZ; Ye QN; Yamaguchi Y; Mukherjee A; Ren DM; Handa H; Li R
Genes Dev; 2004 Sep; 18(17):2134-46. PubMed ID: 15342491
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
19. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
Stenoien DL; Patel K; Mancini MG; Dutertre M; Smith CL; O'Malley BW; Mancini MA
Nat Cell Biol; 2001 Jan; 3(1):15-23. PubMed ID: 11146621
[TBL] [Abstract][Full Text] [Related]
20. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.
Lonard DM; Nawaz Z; Smith CL; O'Malley BW
Mol Cell; 2000 Jun; 5(6):939-48. PubMed ID: 10911988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
